Dung Tran
Psychiatry · Bethlehem, PANPI 1851320444
Payments from drug & device makers
Across 182 payments — averaging $48.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$3K
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Johnson & Johnson$906
- Neurocrine Biosciences, Inc.$770
- Otsuka America Pharmaceutical, Inc.$759
- plus $1K from 6 others
What the payments were for
- Food & beverage$8,74099%
- Education$1181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 65 | $2,558 |
| Alkermes, Inc. | 15 | $1,314 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $1,099 |
| Johnson & Johnson | 19 | $906 |
| Neurocrine Biosciences, Inc. | 12 | $770 |
| Otsuka America Pharmaceutical, Inc. | 27 | $759 |
| AbbVie(2 entities) | 18 | $543 |
| E.r. Squibb & Sons, L.L.C. | 3 | $348 |
| Axsome Therapeutics, Inc. | 2 | $249 |
| Indivior Inc. | 2 | $137 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Sunovion Pharmaceuticals Inc. | 3 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,939
- ARISTADA$1,900
- AUSTEDO$687
- INGREZZA$623
- CAPLYTA$612
- UZEDY$499
- ARISTADA INITIO$475
- VRAYLAR$471
- Austedo XR$461
- INVEGA SUSTENNA$355
- COBENFY$348
- Auvelity$249
- REXULTI$238
- SPRAVATO$125
- PERSERIS$125
- Fanapt$125
- ABILIFY MAINTENA$113
How this compares
$8,858 in reported general payments places this provider in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 89 | $248,038 |
| Abilify MaintenaAripiprazole | 38 | $98,559 |
| CaplytaLumateperone Tosylate | 13 | $21,396 |
| Clozapine | 400 | $20,160 |
| VraylarCariprazine Hcl | 12 | $17,704 |
| AristadaAripiprazole Lauroxil | 11 | $16,680 |
| Fluphenazine Hcl | 58 | $7,610 |
| Paliperidone ErPaliperidone | 31 | $5,793 |
| Olanzapine | 166 | $3,860 |
| Atropine Sulfate | 34 | $2,016 |
| Lamotrigine ErLamotrigine | 15 | $1,880 |
| Hydroxyzine Hcl | 136 | $1,570 |
| Divalproex Sodium | 51 | $1,356 |
| Haloperidol Decanoate | 28 | $1,187 |
| Lithium Carbonate ErLithium Carbonate | 62 | $1,000 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $906 | $248,03889 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $759 | $98,55938 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,099 | $21,39613 claims |
| AbbVieVraylar | $543 | $17,70412 claims |
| Alkermes, Inc.Aristada | $1,314 | $16,68011 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $2,558 | $38333 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Bethlehem
- Abel GonzalezBethlehem$74K
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.